Novo Nordisk's raised forecast fails to change the debate over its obesity business

Thread starter International: Top News And Analysis
Start date Aug 5, 2026

International: Top News And Analysis

Guest

Aug 5, 2026

Wall Street isn't convinced the Ozempic maker has a promising path back to sustainable growth as competition from Eli Lilly intensifies.

Continue reading...

You must log in or register to reply here.

Facebook X Bluesky LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

Thread Information

Title: Novo Nordisk's raised forecast fails to change the debate over its obesity business

Prefix: N/A

Forum: World News

Start date: Aug 5, 2026

Last reply date: Aug 5, 2026

Replies: 0

Thread Tags

Thread statistics

Created: International: Top News And Analysis, Aug 5, 2026

Replies: 0

Views: 10

About Us

XenTR Lorem Ipsum has been the industry's standard dummy text ever since the 1500s, when an unknown printer took a galley of type and scrambled it to make a type specimen book.

It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout.

Color picker

Search